MT Genex Corporation (TYO:9820)
Japan · Delayed Price · Currency is JPY 3,795.00
+55.00 (1.47%)
Aug 27, 2026, 3:30 PM JST
MT Genex Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 3,561 | 1,993 | 2,007 | 1,835 | 1,833 | 1,846 |
Cash & Short-Term Investments | 3,561 | 1,993 | 2,007 | 1,835 | 1,833 | 1,846 |
Cash Growth | 67.73% | -0.70% | 9.37% | 0.11% | -0.70% | 20.73% |
Accounts Receivable | 1,597 | 1,037 | 511 | 497 | 442 | 235 |
Receivables | 2,097 | 3,037 | 2,511 | 2,497 | 2,442 | 2,235 |
Inventory | 50 | 28 | 1 | - | 2 | 1 |
Other Current Assets | 47 | 60 | 44 | 39 | 43 | 40 |
Total Current Assets | 5,755 | 5,118 | 4,563 | 4,371 | 4,320 | 4,122 |
Property, Plant & Equipment | 202 | 207 | 205 | 207 | 176 | 137 |
Long-Term Investments | 121 | 120 | 114 | 124 | 98 | 120 |
Goodwill | 84 | 92 | 140 | 205 | 86 | 120 |
Other Intangible Assets | 2 | 1 | 2 | 1 | 1 | 2 |
Long-Term Deferred Tax Assets | 99 | 105 | 96 | 91 | 79 | 86 |
Other Long-Term Assets | - | 2 | 1 | 2 | 2 | 1 |
Total Assets | 6,263 | 5,645 | 5,121 | 5,001 | 4,762 | 4,588 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 1,008 | 494 | 312 | 345 | 218 | 168 |
Accrued Expenses | 55 | 63 | 54 | 48 | 28 | 29 |
Short-Term Debt | - | - | - | - | - | 6 |
Current Portion of Long-Term Debt | 17 | 17 | 17 | 33 | 33 | 33 |
Current Income Taxes Payable | 105 | 113 | 82 | 119 | 85 | 106 |
Other Current Liabilities | 182 | 183 | 165 | 168 | 356 | 322 |
Total Current Liabilities | 1,367 | 870 | 630 | 713 | 720 | 664 |
Long-Term Debt | 60 | 66 | 84 | 137 | 148 | 211 |
Pension & Post-Retirement Benefits | 132 | 130 | 123 | 126 | 118 | 142 |
Other Long-Term Liabilities | 184 | 179 | 156 | 117 | 102 | 96 |
Total Liabilities | 1,743 | 1,245 | 993 | 1,093 | 1,088 | 1,113 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 1,072 | 1,072 | 1,072 | 1,072 | 1,072 | 1,072 |
Retained Earnings | 3,460 | 3,340 | 3,068 | 2,846 | 2,611 | 2,413 |
Treasury Stock | -12 | -12 | -11 | -11 | -11 | -11 |
Comprehensive Income & Other | - | - | -1 | 1 | 2 | 1 |
Shareholders' Equity | 4,520 | 4,400 | 4,128 | 3,908 | 3,674 | 3,475 |
Total Liabilities & Equity | 6,263 | 5,645 | 5,121 | 5,001 | 4,762 | 4,588 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 77 | 83 | 101 | 170 | 181 | 250 |
Net Cash (Debt) | 3,484 | 1,910 | 1,906 | 1,665 | 1,652 | 1,596 |
Net Cash Growth | 71.71% | 0.21% | 14.47% | 0.79% | 3.51% | 28.19% |
Net Cash Per Share | 3237.96 | 1775.09 | 1771.38 | 1547.40 | 1535.32 | 1483.27 |
Filing Date Shares Outstanding | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 |
Total Common Shares Outstanding | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 | 1.08 |
Working Capital | 4,388 | 4,248 | 3,933 | 3,658 | 3,600 | 3,458 |
Book Value Per Share | 4199.71 | 4088.21 | 3835.17 | 3630.52 | 3413.07 | 3228.18 |
Tangible Book Value | 4,434 | 4,307 | 3,986 | 3,702 | 3,587 | 3,353 |
Tangible Book Value Per Share | 4119.80 | 4001.80 | 3703.25 | 3439.15 | 3332.25 | 3114.84 |
Order Backlog | - | 2,648 | 278.81 | 250.23 | 182.3 | 264.91 |